Onchocerciasis Fingerprints in the Geriatric Population: Does Host Immunity Play a Role?

One of the most debilitating consequences of aging is the progressive decline in immune function, known as immunosenescence. This phenomenon is characterized by a shift in T-cell phenotypes, with a manifest decrease of naive T-cells—dealing with newly encountered antigens—and a concomitant accumulat...

Full description

Bibliographic Details
Published in:	Tropical Medicine and Infectious Disease
Main Authors:	Cabirou Mounchili Shintouo, Robert Adamu Shey, Tony Mets, Luc Vanhamme, Jacob Souopgui, Stephen Mbigha Ghogomu, Rose Njemini
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Subjects:	onchocerciasis immunosenescence immune dysfunction elderly
Online Access:	https://www.mdpi.com/2414-6366/6/3/153

Similar Items

Preliminary Evaluation of the Diagnostic Performance of OvMANE1 and OvMCBL02 Multiepitope Antigens for the Non-Invasive Diagnosis of Onchocerciasis Exposure
by: Bernis Neneyoh Yengo, et al.
Published: (2025-09-01)

Immunoinformatics Design and Assessment of a Multiepitope Antigen (OvMCBL02) for Onchocerciasis Diagnosis and Monitoring
by: Bernis Neneyoh Yengo, et al.
Published: (2022-06-01)

Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis
by: Cabirou Mounchili Shintouo, et al.
Published: (2021-11-01)

Entomological Assessment of <i>Onchocerca</i> Species Transmission by Black Flies in Selected Communities in the West Region of Cameroon
by: Cabirou Mounchili Shintouo, et al.
Published: (2020-09-01)

In Silico Design and Validation of OvMANE1, a Chimeric Antigen for Human Onchocerciasis Diagnosis
by: Cabirou Mounchili Shintouo, et al.
Published: (2020-06-01)

The Functional Parasitic Worm Secretome: Mapping the Place of <i>Onchocerca volvulus</i> Excretory Secretory Products
by: Luc Vanhamme, et al.
Published: (2020-11-01)

Computational Design and Preliminary Serological Analysis of a Novel Multi-Epitope Vaccine Candidate Against Onchocerciasis and Related Filarial Diseases
by: Robert Adamu Shey, et al.
Published: (2021-01-01)

Onchocerciasis in the forest-savannah mosaic area of Nigeria
by: C P Chijioke, et al.
Published: (1998-01-01)

Information for onchocerciasis control
by: Adrian Hopkins
Published: (2010-12-01)

Psycho-social and Economic Evaluation of Onchocerciasis: A Literature Review
by: Laura Moya Alonso, et al.
Published: (2009-02-01)

Onchocerciasis in Ecuador: the situation in 1989
by: Ronald H. Guderian, et al.
Published: (1992-09-01)

Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening
by: Alfred Dusabimana, et al.
Published: (2022-02-01)

Epilepsy in the onchocerciasis endemic area of Deim Zubeir, South Sudan: a household survey
by: Jurel Payii Mamur, et al.
Published: (2025-02-01)

Prediction of community prevalence of human onchocerciasis in the Amazonian onchocerciasis focus: Bayesian approach
by: Carabin Hélène, et al.
Published: (2003-01-01)

Onchocerciasis status in Guinea-Bissau: An overview of trends in epidemiological and entomological indicators
by: Natalie. V.S. Vinkeles Melchers, et al.
Published: (2025-10-01)

Ivermectin therapy for onchocerciasis: Effect on some haematological and biochemical parameters
by: E N Shu, et al.
Published: (2008-01-01)

Onchocerciasis in Ecuador: Prevalence of Infection on the Ecuador-Colombia Border in the Province of Esmeraldas
by: Joy R Guderian, et al.
Published: (1997-03-01)

Recognising the neurological burden of onchocerciasis: the need to include onchocerciasis-associated epilepsy in onchocerciasis global health metrics
by: Luís-Jorge Amaral, et al.
Published: (2025-03-01)

Spatial clustering of onchocerciasis in Bioko Island, Equatorial Guinea
by: Diana Gómez-Barroso, et al.
Published: (2018-11-01)

Status of Onchocerciasis Elimination in Gabon and Challenges: A Systematic Review
by: Elsa-Rush Eyang-Assengone, et al.
Published: (2023-07-01)

No Evidence Known Viruses Play a Role in the Pathogenesis of Onchocerciasis-Associated Epilepsy. An Explorative Metagenomic Case-Control Study
by: Michael Roach, et al.
Published: (2021-06-01)

Investigation of publication trends and hot topics on onchocerciasis between 2000 and 2022
by: Sevil Alkan, et al.
Published: (2023-09-01)

Cytokines and Onchocerciasis-Associated Epilepsy, a Pilot Study and Review of the Literature
by: Melissa Krizia Vieri, et al.
Published: (2021-03-01)

Knowledge and Practices of Four Onchocerciasis-Endemic Communities in Cameroon
by: Kamtsap Pierre, et al.
Published: (2025-03-01)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: M. Winnen, et al.

Predictors of compliance with community-directed treatment with ivermectin for onchocerciasis control in Kabo area, southwestern Ethiopia
by: Adugna Endale, et al.
Published: (2015-02-01)

Stability analysis of a class of onchocerciasis model
by: LI Longying; LIU Junli
Published: (2022-09-01)

Presumed Onchocerciasis Chorioretinitis Spilling over into North America, Europe and Middle East
by: Ahmad Mansour, et al.
Published: (2023-12-01)

The Impact of Onchocerciasis Elimination Measures in Africa: A Systematic Review
by: Policarpo Ncogo, et al.
Published: (2024-12-01)

Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed
by: Robert Colebunders, et al.
Published: (2024-01-01)

Entomological surveillance of onchocerciasis in Burkina Faso: Progress towards interrupting transmission in blackflies in the main river basins of the country
by: Lassane Koala, et al.
Published: (2025-01-01)

Persistent transmission of onchocerciasis in Kwanware-Ottou focus in Wenchi health district, Ghana
by: Rogers Nditanchou, et al.
Published: (2024-10-01)

Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin
by: Uwem F. Ekpo, et al.
Published: (2022-11-01)

Anticoagulant activity in salivary gland homogenates of Thyrsopelma guianense (Diptera: Simuliidae), the primary vector of onchocerciasis in the Brazilian Amazon
by: Andrezza Campos Chagas, et al.
Published: (2010-03-01)

Awareness of and participation in mass drug administration programs used for onchocerciasis control in the Atwima Nwabiagya North District, Ghana
by: Francis Adjei Osei, et al.
Published: (2023-11-01)

The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data
by: Hugo C Turner, et al.
Published: (2015-03-01)

Epidemiology of epilepsy in Wulu County, an onchocerciasis-endemic area in South Sudan
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2024-09-01)

No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy
by: An Hotterbeekx, et al.
Published: (2021-07-01)

Onchocerciasis in West Africa after 2002: a challenge to take up
by: Hougard J.M., et al.
Published: (2002-06-01)

Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
by: Wilma A. Stolk, et al.
Published: (2015-10-01)